The @clearvisionanu lab is joining forces with Korean biotech firm MDimune to create more effective treatments for age-related macular degeneration.
The chronic disease is the leading cause of blindness in the developed world.
@JCSMR
https://t.co/n8Y4MZ7d7c
Delighted to have been selected as a recipient of the 2023 Rhodes Scholarship for Australia-at-large.
I look forward to studying a DPhil at Oxford and tackling neurodegenerative disease on the world stage!
https://t.co/giRJxczBk6
@rhodes_trust@UniofOxford
“RNA has revolutionised vaccine development, but we’ve only scratched the surface of its potential.”
Glad to have this piece out that I wrote with @ANUClearVision about the potential of RNA #RNA#research
“This will change the standard of care for many diseases”
Be sure to check out our piece in @abcnews on the therapeutic potential of #RNA, and how it can be used to combat disease.
@ANUmedia@JCSMR@ANUClearVision@joshchutan
https://t.co/imKlbkU6WJ
Unique molecular signals in the body identified by #ANUExperts could help scientists "bottle up" the benefits of exercise in a pill for at-risk patients. 🧠🏃💊
The messages are sent to our brain & potentially our eyes immediately after we exercise.
📖 https://t.co/4n8K2rFM5t
Our 17th issue of the year is now complete!
The cover shows microRNA-reprogrammed mouse Muller glia, from @WohlStefanie & colleagues
https://t.co/azoZRYobRW
A news story on some of the work being conducted by my research group, Clear Vision Research, at the Australian National University (ANU). So proud of our team and the efforts of all involved. - https://t.co/uUsQRgYlIJ